Actavia Life Sciences, Inc. (OTCPK: RASP)
Health Care · Biotechnology · US
$—
— today · — 1Y
Actavia Life Sciences, Inc. (OTCPK: RASP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $385.91K and employs 1 people.
trading between 0.00 and 0.01.
Tweenvest scores Actavia Life Sciences, Inc. across four factors: quality 33/100, value 25/100. Its strongest factor is quality.
RASP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $385.91K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -84.20
- 52-week high
- $0.01
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 771.81M
- Employees
- 1
- Next earnings
- —
About Actavia Life Sciences, Inc.
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
- ISIN
- US7538881068
- Founded
- 2013
- Listed since
- Feb 24, 2015
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NovelStem International Corp.OTCPK: NSTM | $468.66K | $0.01 | -7.41% |
| Sorrento Therapeutics, Inc.OTCPK: SRNE | $434.97K | $0.00 | +166.67% |
| Vaxil Bio Ltd.TSXV: VXL | $405.24K | CA$0.15 | -3.33% |
| Asia Green Biotechnology Corp.CNSX: ASIA | $400.48K | CA$— | — |
| Waverley Pharma Inc.TSXV: WAVE | $385.12K | CA$0.01 | -33.33% |
| Paion AGDB: PA8K | $369.33K | €0.05 | -9.80% |
| Nextel Medical Corp.OTCPK: MAJI | $305.95K | $0.00 | -25.00% |
| Longevity Health Holdings, Inc.OTCPK: XAGE | $305.70K | $0.12 | -20.88% |
Figures last refreshed Oct 4, 2026.